The upregulation of HGFL in the TRAMP+ model was further supported by a large human prostate cancer data analysis wherein HGFL protein levels were found to be significantly increased in prostate carcinomas compared to minimal levels observed in normal tissue. Here, MST1 is linked to prostate cancer.